![Andreas Norlin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andreas Norlin
Teknisk/Vetenskaplig/F&U Direktör på
ASCELIA PHARMA AB
Profil
Andreas L.
Norlin is the founder of Xkout Bioscience AB. Dr. Norlin currently holds the positions of Director at ApoGlyx AB, Director at Desupervised ApS, and Chief Scientific Officer at Ascelia Pharma AB since 2020.
Dr. Norlin completed graduate and doctorate degrees at the University of Lund.
Aktiva positioner av Andreas Norlin
| Företag | Position | Start |
|---|---|---|
| ASCELIA PHARMA AB | Teknisk/Vetenskaplig/F&U Direktör | 2020-01-01 |
ApoGlyx AB
 ApoGlyx AB BiotechnologyHealth Technology Engages in research and development in biochemistry | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Andreas Norlin
| Företag | Position | Slut |
|---|---|---|
Xkout Bioscience AB | Grundare | - |
Andreas Norlins utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
19
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ApoGlyx AB
ApoGlyx AB BiotechnologyHealth Technology Engages in research and development in biochemistry | Health Technology |
Ascelia Pharma AB
 Ascelia Pharma AB Pharmaceuticals: MajorHealth Technology Operates as oncology-dedicated drug development company, which develops novel drugs to improve life expectancy | Health Technology |
Xkout Bioscience AB |
